48,830
edits
Line 35: | Line 35: | ||
*Most common malignant sarcoma in the retroperitoneum. | *Most common malignant sarcoma in the retroperitoneum. | ||
*Not all (large) retroperitoneal adipocytic tumours are liposarcomas. | *Not all (large) retroperitoneal adipocytic tumours are liposarcomas. | ||
*Prognosis - good- | *Prognosis - dependent on the location. | ||
**Retroperitoneal: poor. | |||
**Extremity: good - disease specific 5-year survival ~ 92%.<ref>{{Cite journal | last1 = Lietman | first1 = SA. | last2 = Barsoum | first2 = WK. | last3 = Goldblum | first3 = JR. | last4 = Marks | first4 = KE. | last5 = Mascha | first5 = E. | last6 = Sundaram | first6 = M. | last7 = Muschler | first7 = G. | title = A 20-year retrospective review of surgically treated liposarcoma at the Cleveland Clinic. | journal = Orthopedics | volume = 30 | issue = 3 | pages = 227-34 | month = Mar | year = 2007 | doi = | PMID = 17375550 }}</ref> | |||
Notes: | Notes: |
edits